QuantiPath
PrivateLast Round
Seed Round
Feb 5, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QuantiPath operates in Healthcare & Life Sciences and is based in Denver, Colorado. It was founded in 2024.
QuantiPath is a biotechnology company that operates a genetic testing technology platform intended for precise identification and quantification of Salmonella serovars.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Compliance
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QuantiPath Comparables
Compare QuantiPath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neogen Corporation | 73% | |
| Bio-Rad Laboratories | 73% | |
| Thermo Fisher Scientific Inc. | 73% |
For institutional investors. Book with your work email.
QuantiPath Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Feb 5, 2026
Raised $1M in Seed Round funding.
For institutional investors. Book with your work email.
QuantiPath Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about QuantiPath's valuation, stock price, and market status.
Is QuantiPath a public or private company?
QuantiPath is a private company.
What is the current stock price of QuantiPath?
QuantiPath is a private company, so its shares have no public market price. Caplight tracks QuantiPath's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is QuantiPath worth (valuation)?
Valuation information for QuantiPath is not publicly available.
Can I buy QuantiPath stock?
QuantiPath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was QuantiPath's last funding round?
QuantiPath's most recent funding round was Seed Round on February 5, 2026.
Who are the main investors in QuantiPath?
Investor information for QuantiPath is not publicly disclosed.
Will QuantiPath IPO soon?
No public IPO plans have been announced for QuantiPath.
How can I track QuantiPath secondary market activity?
Caplight tracks bids, offers, and trades in QuantiPath's shares on secondary markets.